XML 28 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activities

The activity for stock options is as follows:

 

 

 

Options
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contract Terms
(in years)

 

 

Aggregate
Intrinsic
Values
(in thousands)

 

Balance as of December 31, 2022

 

 

5,988,271

 

 

$

4.70

 

 

 

8.83

 

 

$

5,699

 

Options granted

 

 

50,000

 

 

 

3.00

 

 

 

 

 

 

 

Options cancelled and forfeited

 

 

(258,415

)

 

 

8.12

 

 

 

 

 

 

 

Options exercised

 

 

(889,404

)

 

 

0.62

 

 

 

 

 

 

1,987

 

Balance as of September 30, 2023

 

 

4,890,452

 

 

$

5.25

 

 

 

3.06

 

 

$

1,316

 

Vested and expected to vest, September 30, 2023

 

 

4,890,452

 

 

$

5.25

 

 

 

3.06

 

 

$

1,316

 

Options exercisable as of September 30, 2023

 

 

4,013,104

 

 

$

5.25

 

 

 

1.85

 

 

$

1,078

 

 

Summary of Stock Options Valuation Assumptions

The fair value of the Company’s stock option awards was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions for the nine months ended September 30, 2023 and 2022:

 

 

 

Nine Months Ended September 30,

 

 

2023

 

2022

Expected term (in years)

 

5.50

 

5.50 - 6.50

Expected volatility

 

92.90%

 

77.33% - 80.54%

Risk-free interest rate

 

3.69%

 

1.69% - 3.03%

Expected dividend yield

 

0.00%

 

0.00%

Summary of Restricted Stock Awards

The activity for restricted stock awards and units is as follows:

 

 

 

Number of Shares

 

 

Weighted-Average
Grant Date Fair Value

 

Unvested at December 31, 2022

 

 

177,494

 

 

$

8.32

 

Granted

 

 

113,333

 

 

 

3.64

 

Vested

 

 

(90,918

)

 

 

7.01

 

Forfeited

 

 

(13,746

)

 

 

8.17

 

Unvested at September 30, 2023

 

 

186,163

 

 

$

6.13

 

Summary of Share-based Compensation Expense

The following table sets forth stock-based compensation for stock options, restricted stock awards, and restricted stock units included in the Company’s condensed consolidated statements of operations and comprehensive loss (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Research and development expense

 

$

429

 

 

$

657

 

 

$

1,889

 

 

$

1,872

 

General and administrative expense

 

 

227

 

 

 

1,126

 

 

 

9,715

 

 

 

3,224

 

Total stock-based compensation expense

 

$

656

 

 

$

1,783

 

 

$

11,604

 

 

$

5,096